Zee Phyllis C, Attarian Hrayr, Videnovic Aleksandar
Northwestern University, 710 North Lake Shore Dr, Chicago, IL 60611, USA.
Continuum (Minneap Minn). 2013 Feb;19(1 Sleep Disorders):132-47. doi: 10.1212/01.CON.0000427209.21177.aa.
This article reviews the recent advances in understanding of the fundamental properties of circadian rhythms and discusses the clinical features, diagnosis, and treatment of circadian rhythm sleep disorders (CRSDs).
Recent evidence strongly points to the ubiquitous influence of circadian timing in nearly all physiologic functions. Thus, in addition to the prominent sleep and wake disturbances, circadian rhythm disorders are associated with cognitive impairment, mood disturbances, and increased risk of cardiometabolic disorders. The recent availability of biomarkers of circadian timing in clinical practice has improved our ability to identify and treat these CRSDs.
Circadian rhythms are endogenous rhythms with a periodicity of approximately 24 hours. These rhythms are synchronized to the physical environment by social and work schedules by various photic and nonphotic stimuli. CRSDs result from a misalignment between the timing of the circadian rhythm and the external environment (eg, jet lag and shift work) or a dysfunction of the circadian clock or its afferent and efferent pathways (eg, delayed sleep-phase, advanced sleep-phase, non-24-hour, and irregular sleep-wake rhythm disorders). The most common symptoms of these disorders are difficulties with sleep onset and/or sleep maintenance and excessive sleepiness that are associated with impaired social and occupational functioning. Effective treatment for most of the CRSDs requires a multimodal approach to accelerate circadian realignment with timed exposure to light, avoidance of bright light at inappropriate times, and adherence to scheduled sleep and wake times. In addition, pharmacologic agents are recommended for some of the CRSDs. For delayed sleep-phase, non-24-hour, and shift work disorders, timed low-dose melatonin can help advance or entrain circadian rhythms; and for shift work disorder, wake-enhancing agents such as caffeine, modafinil, and armodafinil are options for the management of excessive sleepiness.
本文综述了对昼夜节律基本特性理解的最新进展,并讨论了昼夜节律睡眠障碍(CRSDs)的临床特征、诊断和治疗。
最近的证据有力地表明,昼夜节律在几乎所有生理功能中都具有普遍影响。因此,除了明显的睡眠和觉醒障碍外,昼夜节律紊乱还与认知障碍、情绪障碍以及心脏代谢紊乱风险增加有关。临床实践中昼夜节律生物标志物的出现提高了我们识别和治疗这些CRSDs的能力。
昼夜节律是周期约为24小时的内源性节律。这些节律通过社会和工作时间表以及各种光和非光刺激与物理环境同步。CRSDs是由昼夜节律的时间与外部环境之间的失调(如时差和轮班工作)或昼夜节律时钟及其传入和传出途径的功能障碍(如睡眠相位延迟、睡眠相位提前、非24小时和不规则睡眠-觉醒节律障碍)引起的。这些障碍最常见的症状是入睡和/或维持睡眠困难以及过度嗜睡,这与社会和职业功能受损有关。大多数CRSDs的有效治疗需要采取多模式方法,通过定时暴露于光线下、在不适当的时间避免强光以及坚持定时的睡眠和觉醒时间来加速昼夜节律重新调整。此外,对于某些CRSDs推荐使用药物。对于睡眠相位延迟、非24小时和轮班工作障碍,定时低剂量褪黑素有助于提前或调整昼夜节律;对于轮班工作障碍,咖啡因、莫达非尼和阿莫达非尼等促醒药物是治疗过度嗜睡的选择。